• Arkin F, 2019: Dengue researcher faces charges in vaccine fiasco[J]. Science, 364, 320-.

  • Aye KS, Charngkaew K, Win N, 2014: Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar[J]. Hum Pathol, 45, 1221-1233.

  • Balakrishnan T, Bela-Ong DB, Toh YX, 2011: Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection[J]. PLoS ONE, 6, e29430-.

  • Bhatt S, Gething PW, Brady OJ, 2013: The global distribution and burden of dengue[J]. Nature, 496, 504-507.

  • Blackley S, Kou Z, Chen H, 2007: Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro[J]. J Virol, 81, 13325-13334.

  • Buddhari D, Aldstadt J, Endy TP, 2014: Dengue virus neutralizing antibody levels associated with protection from infection in Thai Cluster studies[J]. PLoS Negl Trop Dis, 8, 1-10.

  • Burke DS, Scott RM, Johnson DE, Nisalak A, 1988: A prospective study of dengue infections in Bangkok[J]. Am J Trop Med Hyg, 38, 172-180.

  • Cannon MJ, Stott EJ, Taylor G, Askonas BA, 1987: Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells[J]. Immunology, 62, 133-138.

  • Cerny D, Haniffa M, Shin A, 2014: Selective susceptibility of human skin antigen presenting cells to productive dengue virus infection[J]. PLoS Pathog, 10, e1004548-.

  • Chandele A, Sewatanon J, Gunisetty S, 2016: Characterization of human CD8 T cell responses in dengue virus-infected patients from India[J]. J Virol, 90, 11259-11278.

  • Channappanavar R, Fett C, Zhao J, 2014: Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection[J]. J Virol, 88, 11034-11044.

  • Chatterjee P, 2019: Dengvaxia researcher charged[J]. Lancet Infect Dis, 19, 584-585.

  • Correa ARV, Berbel ACER, Papa MP, 2015: Dengue virus directly stimulates Polyclonal B cell activation[J]. PLoS ONE, 10, 1-20.

  • Cyster JG, Schwab SR, 2012: Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs[J]. Annu Rev Immunol, 30, 69-94.

  • Dick OB, San Martín JL, Montoya RH, 2012: Review: the history of dengue outbreaks in the Americas[J]. Am J Trop Med Hyg, 87, 584-593.

  • Dung NTP, Le DH, Van TN, 2010: Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue[J]. J Immunol, 184, 7281-7287.

  • Endy TP, Chunsuttiwat S, Nisalak A, 2002: Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand[J]. Am J Epidemiol, 156, 40-51.

  • Flajnik MF, 2018: A cold-blooded view of adaptive immunity[J]. Nat Rev Immunol, 18, 438-453.

  • Flemming W, 1885: Studien über Regeneration der Gewebe[J]. Arch mikr Anat, 24, 50-91.

  • Friberg H, Bashyam H, Toyosaki-Maeda T, 2011: Cross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans[J]. Sci Rep, 1, 1-9.

  • Garcia-Bates TM, Cordeiro MT, Nascimento EJM, 2013: Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients[J]. J Immunol, 190, 80-87.

  • Gawoski JM, Ooi WW, 2003: Dengue fever mimicking plasma cell leukemia[J]. Arch Pathol Lab Med, 127, 1026-1027.

  • Glaum MC, Narula S, Song D, 2009: Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production[J]. J Allergy Clin Immunol, 123, 224.e4-230.e4.

  • Godoy-Lozano EE, Téllez-Sosa J, Sánchez-González G, 2016: Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response[J]. Genome Med, 8, 1-19.

  • Graham RR, Juffrie M, Tan R, 1999: A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia Ⅰ. Studies in 1995-1996[J]. Am J Trop Med Hyg, 61, 412-419.

  • Green S, Pichyangkul S, Vaughn DW, 1999: Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever[J]. J Infect Dis, 180, 1429-1435.

  • Halstead SB, 1970: Observations related to pathogensis of dengue hemorrhagic fever. Ⅵ. Hypotheses and discussion[J]. Yale J Biol Med, 42, 350-362.

  • Halstead SB, O'Rourke EJ, 1977: Antibody-enhanced dengue virus infection in primate leukocytes[J]. Nature, 265, 739-741.

  • Hardie DL, Johnson GD, Khan M, MacLennan ICM, 1993: Quantitative analysis of molecules which distinguish functional compartments within germinal centers[J]. Eur J Immunol, 23, 997-1004.

  • Hor JL, Whitney PG, Zaid A, 2015: spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4+ and CD8+ T cell activation to localized viral infection[J]. Immunity, 43, 554-565.

  • Jampangern W, Vongthoung K, Jittmittraphap A, 2007: Characterization of atypical lymphocytes and immunophenotypes of lymphocytes in patients with dengue virus infection[J]. Asian Pac J Allergy Immunol, 25, 27-36.

  • Jellison ER, Guay HM, Szomolanyi-Tsuda E, Welsh RM, 2007: Dynamics and magnitude of virus-induced polyclonal B cell activation mediated by BCR-independent presentation of viral antigen[J]. Eur J Immunol, 37, 119-128.

  • MacLennan IC, 1994: Germinal centers[J]. Annu Rev Immunol, 12, 117-139.

  • Malavige GN, Ogg GS, 2013: T cell responses in dengue viral infections[J]. J Clin Virol, 58, 605-611.

  • Marcial-Juárez E, Yam-Puc JC, Cedillo-Barrón L et al (2017) Travelling with dengue: from the skin to the nodes. In: Aparecida Sperança M (ed) Dengue: immunopathology and control strategies, 1st edn. IntechOpen Limited, London, pp 27-42

  • Mathew A, Kurane I, Green S, 1999: Impaired T cell proliferation in acute dengue infection[J]. J Immunol, 162, 5609-5615.

  • Mongkolsapaya J, Dejnirattisai W, Xu X, 2003: Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever[J]. Nat Med, 9, 921-927.

  • Mongkolsapaya J, Duangchinda T, Dejnirattisai W, 2006: T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?[J]. J Immunol, 176, 3821-3829.

  • Ndhlovu ZM, Kamya P, Mewalal N, 2015: Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point[J]. Immunity, 43, 591-604.

  • Nightingale ZD, Patkar C, Rothman AL, 2008: Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus[J]. J Leukoc Biol, 84, 1028-1038.

  • Nivarthi UK, Tu HA, Delacruz MJ, 2019: Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model[J]. EBioMedicine, 41, 465-478.

  • Rivino L, 2016: T cell immunity to dengue virus and implications for vaccine design[J]. Expert Rev Vaccines, 15, 443-453.

  • Rothman AL, 2004: Dengue: defining protective versus pathologic immunity[J]. J Clin Invest, 113, 946-951.

  • Rush B (1789) An account of the bilious remitting fever, as it appeared in Philadelphia in the summer and autumn of the year 1780, Medical In. Prichard and Hall, Philadelphia

  • Sabin AB, 1952: Research on Dengue during World War Ⅱ 1[J]. Am J Trop Med Hyg, 1, 30-50.

  • Sangkawibha N, Rojanasuphot S, Ahandrik S, 1984: Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand: Ⅰ. The 1980 outbreak[J]. Am J Epidemiol, 120, 653-669.

  • Screaton G, Mongkolsapaya J, Yacoub S, Roberts C, 2015: New insights into the immunopathology and control of dengue virus infection[J]. Nat Rev Immunol, 15, 745-759.

  • Slütter B, Pewe LL, Kaech SM, Harty JT, 2013: Lung airway-surveilling CXCR3hi Memory CD8+ T cells are critical for protection against influenza A virus[J]. Immunity, 39, 939-948.

  • Taylor PM, Askonas BA, 1986: Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo[J]. Immunology, 58, 417-420.

  • WHO (2012) Global strategy for dengue prevention and control 2012-2020. WHO Press, Geneva

  • WHO (2019) Dengue and severe dengue. In: WHO. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue. Accessed 30 Sep 2019

  • Wrammert J, Onlamoon N, Akondy RS, 2012: Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans[J]. J Virol, 86, 2911-2918.

  • Wu S-JJ, Grouard-Vogel G, Sun W, 2000: Human skin Langerhans cells are targets of dengue virus infection[J]. Nat Med, 6, 816-820.

  • Yam-Puc JC, García-Cordero J, Calderón-Amador J, 2015: Germinal center reaction following cutaneous dengue virus infection in immune-competent mice[J]. Front Immunol, 6, 1-9.

  • Yap KL, Ada GL, McKenzie IFC, 1978: Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus[J]. Nature, 273, 238-239.